Caligan Partners »

Miragen Therapeutics shares owned by Caligan Partners

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Caligan Partners from 13F filings

Historical chart of Caligan Partners investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Caligan Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Caligan Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $40M 2.2M 18.37

More positions owned by Caligan Partners

Liquidia Corporation Com New (LQDA)
Revolution Medicines (RVMD)
Abivax Sa Sponsored Ads (ABVX)
Vaxcyte (PCVX)
Exelixis (EXEL)
Tango Therapeutics (TNGX)
Avalo Therapeutics Com New (AVTX)
Xenon Pharmaceuticals (XENE)
Adma Biologics (ADMA)
Lb Pharmaceuticals Com Shs (LBRX)
Immunocore Hldgs Ads (IMCR)
Miragen Therapeutics (VRDN)
Vor Biopharma Com New (VOR)
Sab Biotherapeutics Com New (SABS)
Inventiva Sa Ads (IVA)

View all positions for Caligan Partners

Top funds holding Miragen Therapeutics

FMR
BlackRock
Bellevue Group
Paradigm Biocapital Advisors
Kynam Capital Management
Fairmount Funds Management
State Street Corporation
Vanguard Capital Management
VR Adviser
T. Rowe Price Associates
Wellington Management Company
Vanguard Portfolio Management
Geode Capital Management
venBio Select Advisor
Baker Bros. Advisors

View all funds holding Miragen Therapeutics